FibroGen Q3 EPS $(0.57) Misses $(0.55) Estimate, Sales $33.17M Beat $31.6M Estimate

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 3.64 percent. This is a 14 percent decrease over losses of $(0.5) per share from the same

Benzinga · 11/11/2019 21:02

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 3.64 percent. This is a 14 percent decrease over losses of $(0.5) per share from the same period last year. The company reported quarterly sales of $33.17 million which beat the analyst consensus estimate of $31.6 million by 4.97 percent. This is a 14.27 percent increase over sales of $29.027 million the same period last year.